Potential risk of inadvertent germ-line gene transmission statement from the American Society of Gene Therapy to the NIH Recombinant DNA Advisory Committee, March 12, 1999.
Wilson
J M
JM
Wivel
N A
NA
D002986:Clinical Trials as Topic; D004274:DNA, Recombinant / Q000627:therapeutic use; D018014:Gene Transfer Techniques / Q000009:adverse effects; D015316:Genetic Therapy / Q000009:adverse effects* / Q000331:legislation & jurisprudence; D005822:Genetic Vectors; D005854:Germ Cells; D006066:Gonads; D006801:Humans; D008297:Male; D009316:National Institutes of Health (U.S.); D009865:Oocytes; D011367:Professional Staff Committees; D012307:Risk Factors; D012958:Societies, Scientific; D013094:Spermatozoa; D014481:United States
D004274:DNA, Recombinant